ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,040.53
      -0.50%
      US Tech 100
      20,778.00
      -0.69%
      Dow Jones
      44,544.66
      -0.75%
      Brent Oil
      76.385
      0.00%
      Bitcoin
      98,123.39
      -2.53%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. CervoMed Inc (CRVO) Quote

      CervoMed Inc

      CervoMed Inc (CRVO)

      NASDAQ
      2.26
      0.01
      (0.44%)
      Closed February 02 4:00PM
      Delayed by 15 minutes
      2.22
      -0.04
      (-1.77%)
      After Hours: 5:19PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      2.22
      Bid
      2.20
      Ask
      2.38
      Volume
      209,088
      2.21 Day's Range 2.38
      1.80 52 Week Range 26.3789
      Market Cap
      18.323M
      Previous Close
      2.25
      Open
      2.28
      Last Trade
      20
      @
      2.22
      Last Trade Time
      Financial Volume
      $ 479,870
      VWAP
      2.2951
      Average Volume (3m)
      473,750
      Shares Outstanding
      8,253,741
      Dividend Yield
      -
      PE Ratio
      -16.72
      Earnings Per Share (EPS)
      -0.26
      Revenue
      7.15M
      Net Profit
      -2.17M

      About CervoMed Inc

      Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is tran... Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.cervomed.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      CervoMed Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CRVO. The last closing price for CervoMed was $2.25. Over the last year, CervoMed shares have traded in a share price range of $ 1.80 to $ 26.3789.

      CervoMed currently has 8,253,741 shares outstanding. The market capitalization of CervoMed is $18.57 million. CervoMed has a price to earnings ratio (PE ratio) of -16.72.

      Ask ADVFN Intelligence (AI)

      CRVO Latest News

      More News

      Form 8-K - Current report

      January 31 2025
      Edgar (US Regulatory)

      CervoMed Provides Update on Neflamapimod DLB Program as Part of Presentation at the 8th International Lewy Body Dementia Conference

      — Data from the first 16 weeks of the open-label extension phase of the RewinD-LB trial are expected in 1Q 2025 and will include data from participants who have received capsules from a more...

      January 31 2025
      GlobeNewswire Inc.

      CervoMed to Present at the 8th International Lewy Body Dementia Conference

      BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that...

      January 29 2025
      GlobeNewswire Inc.

      Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

      January 13 2025
      Edgar (US Regulatory)

      CervoMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      BOSTON, Dec. 12, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO) (the “Company”), a clinical stage company focused on developing treatments for age-related neurologic disorders, today...

      December 12 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      December 10 2024
      Edgar (US Regulatory)

      CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies

      —Neflamapimod did not demonstrate statistically significant effects versus placebo on primary and secondary endpoints at 16 weeks— —Favorable safety and tolerability results with no new safety...

      December 10 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      December 03 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 27 2024
      Edgar (US Regulatory)

      CervoMed Announces Orphan Drug Designation Granted to Neflamapimod by U.S. Food and Drug Administration for the Treatment of Frontotemporal Dementia

      Designation underscores significant unmet need in frontotemporal dementia and the potential role of neflamapimod in multiple neurologic disorders On track to report topline data from the RewinD-LB...

      November 27 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.05-2.202643171812.272.352.151282912.25969209CS
      4-0.11-4.721030042922.332.431.98531582222.22538286CS
      12-10.38-82.38095238112.614.41.84737503.42603013CS
      26-11.77-84.131522516113.9920.631.82537665.56506916CS
      52-6.6-74.82993197288.8226.37891.81493077.48559818CS
      156-11.28-83.555555555613.526.37891.81138257.44158703CS
      260-11.28-83.555555555613.526.37891.81138257.44158703CS

      CRVO - Frequently Asked Questions (FAQ)

      What is the current CervoMed share price?
      The current share price of CervoMed is $ 2.22
      How many CervoMed shares are in issue?
      CervoMed has 8,253,741 shares in issue
      What is the market cap of CervoMed?
      The market capitalisation of CervoMed is USD 18.57M
      What is the 1 year trading range for CervoMed share price?
      CervoMed has traded in the range of $ 1.80 to $ 26.3789 during the past year
      What is the PE ratio of CervoMed?
      The price to earnings ratio of CervoMed is -16.72
      What is the cash to sales ratio of CervoMed?
      The cash to sales ratio of CervoMed is 5.08
      What is the reporting currency for CervoMed?
      CervoMed reports financial results in USD
      What is the latest annual turnover for CervoMed?
      The latest annual turnover of CervoMed is USD 7.15M
      What is the latest annual profit for CervoMed?
      The latest annual profit of CervoMed is USD -2.17M
      What is the registered address of CervoMed?
      The registered address for CervoMed is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
      What is the CervoMed website address?
      The website address for CervoMed is www.cervomed.com
      Which industry sector does CervoMed operate in?
      CervoMed operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		729.72M
      REBNReborn Coffee Inc
      $ 3.31
      (63.05%)
      		55.54M
      FCUVFocus Universal Inc
      $ 5.87
      (56.62%)
      		1.73M
      SOPASociety Pass Inc
      $ 1.54
      (56.50%)
      		13.82M
      CYCNCyclerion Therapeutics Inc
      $ 3.92
      (54.33%)
      		82.39M
      ENVBEnveric Biosciences Inc
      $ 2.0899
      (-46.41%)
      		1.57M
      NIVFNewGenIvf Group Ltd
      $ 0.1489
      (-42.51%)
      		14.8M
      GLSTGlobal Star Acquisition Inc
      $ 8.83
      (-39.10%)
      		23.89k
      PRPHProPhase Labs Inc
      $ 0.2633
      (-38.02%)
      		872.46k
      SPGCSacks Parente Golf Inc
      $ 0.5601
      (-37.86%)
      		7.27M
      TCTMTCTM Kids IT Education Inc
      $ 0.764
      (321.87%)
      		729.72M
      NVDANVIDIA Corporation
      $ 120.07
      (-3.67%)
      		388.54M
      RIMEAlgorhythm Holdings Inc
      $ 0.02565
      (5.12%)
      		338.75M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0355
      (-11.25%)
      		236.29M
      CLEUChina Liberal Education Holdings Ltd
      $ 0.1938
      (30.77%)
      		234.8M

      CRVO Discussion

      View Posts
      tw0122 tw0122 4 weeks ago
      $2.20s some more data available Jan 2025 a few buy bites down here
      👍️0
      Covid19freak Covid19freak 2 months ago
      Phase 2b data of dementia trial imminent expected during this month , if positive this one going to 50 dollar and more
      👍️0
      JcOg323 JcOg323 2 months ago
      CRVO is about to pop this DEC!!!
      👍️0
      Monksdream Monksdream 5 months ago
      CRVO directionless
      👍️0

      Your Recent History

      NASDAQ
      CRVO
      CervoMed
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads